OM Pharma

Today we are excited to announce a new licensing agreement granting Duhn Therapeutics, a Landmark BioVentures AG company, global and exclusive rights for the development and commercialisation of DHN198, a clinical-stage, lipid-based cancer immunotherapy. Initially discovered thanks to OM Pharma research around bacterial lysates, DHN198 targets solid cancers associated with or resulting from chronic non-resolved immunosuppressive inflammation. Find out more here: https://lnkd.in/gr3g7xKT #ompharma #healthcare #oncology #immunehealth #partnership #entrepreneurship

Over the last eight months, Anne-Sophie Marqués and Pauline RAVIER took part in a job rotation, allowing them to gain fresh perspectives and collaborate with colleagues across different functions. Find out more about working at OM Pharma and how our team embraces entrepreneurial approaches at work and fosters a culture of continuous learning: https://lnkd.in/dh2U3JCG #OMPharma #Jobrotation #TeamWork

OM Pharma will be at BIO-Europe in November. Join Riccardo Nisato and yannis planoudis to find out more about our preclinical & late-stage pipeline and partnership opportunities. Book a meeting in BIO’s partnering system 👉https://lnkd.in/dCbGGu3z #OMPharma #BIOEurope #Biotech 

 📢 We have relaunched our website with a fresh focus on our OM Pharma story. Find out how we are using our expertise in bacterial lysates to transform immune health and address some of the world's most significant health challenges from antimicrobial resistance through to the rise in infectious disease outbreaks. Visit 👉 ompharma.com #ompharma #healthcare #prevention

At OM Pharma, we prioritise patient safety every day.   🔎 Our pharmacovigilance experts diligently monitor the benefit/risk balance of our products, promptly detect any changes in their safety profile, and inform health authorities, healthcare professionals, and patients. They also ensure the safety of subjects and healthy volunteers participating in clinical trials involving our products.   🌎 Our pharmacovigilance community extends beyond our site, encompassing our global network of partners and suppliers. #OMPharma #WorldPatientSafetyDay #healthcare 

It’s back to school and in some cases back to respiratory infections. With kids coming back to the classrooms after the break and having increased close contact with each other, here are some reminders to help keep kids and adults healthy this season: ✔️ Encourage regular handwashing with soap and water, particularly before meals, after using the toilet, and after coughing or sneezing. ✔️ Teach children to cover their coughs and sneezes with their elbow or a disposable tissue to prevent the spread of germs in the air. ✔️ Strengthen the immune system by prioritizing a balanced diet and a good night’s sleep. A robust immune system is crucial for fighting off infections.   Let's make this school year a healthy one!   #OMPharma #BackToSchool #HealthTips #ImmuneHealth

At the end of August, OM Pharma brought together medical experts from around the world for a two-day event focused on respiratory health and how bacterial lysates can offer possibilities for patient care. As part of this expedition-themed event, experts discussed: 🔹 Impact of recurrent Respiratory Tract Infections 🔹 Immune debt post COVID 🔹 Innovations in treatment approaches 🔹 Practical applications and case studies #OMPharma #Breathbeyondborders #ScientificForum #ImmuneHealth

At OM Pharma, our vision is to transform immune health. Our dynamic marketing team plays a pivotal role in tackling both global and individual health challenges by deeply understanding patients’ needs and driving the success of our cutting-edge, high-quality products that improve the lives of millions of people worldwide. Are you ready to join our global Marketing department in Geneva and make a real impact? We have some exciting opportunities for you: 🚀 Brand Manager (2 positions) 🚀 Business Intelligence Lead 🚀 International Marketing Trainee Discover more and apply 👉 https://lnkd.in/e4_5x5DB #JobOpenings #Teamwork #OMPharma

At the start of summer, Esther Olivas Faching from our Regulatory Affairs & Quality team at OM Pharma Peru completed an enriching exchange at our biotech campus and headquarters in Geneva, immersing herself in the daily operations of our Geneva site. At OM Pharma, we are proud to be an international team, committed to supporting initiatives that foster growth and cross-cultural understanding. Find out more about us here: https://lnkd.in/dh2U3JCG #OMPharma #careers #growth

📢 Today, alongside our partner Fraunhofer ITEM, we announced that the first participant has been dosed in a Phase 1a/1b Clinical Trial Evaluating Safety and Tolerability of OM-85-Intranasal. This innovative route of administration for our bacterial lysate OM-85 aims to provide a rapid and targeted delivery, potentially enhancing its therapeutic benefits for patients with asthma. This is a milestone moment for the OM Pharma pipeline and demonstrates our commitment to transform immune health through innovative new formulations and applications of our bacterial lysates. Find out more: https://lnkd.in/dGfVyGPA #ompharma #clinicaltrials #asthma #innovation